Bile duct connects the liver to the gallbladder and carries bile, which is synthesized by the liver and stored in the gallbladder. The main function of bile is breakdown of fat during digestion. Bile duct cancer is commonly known as cholangiocarcinoma. The specific cause of bile duct cancer is unknown, but few factors that cause bile duct cancer are long-term inflammation in the liver, biliary stones, abnormalities in bile duct such as cysts, infection with liver fluke parasites leading to bile duct leading to cancer, and exposure to harmful chemicals or toxins. Major symptoms associated with bile duct cancer include jaundice, weight loss, loss of appetite, discoloration of urine and stool, abdominal pain, itching, and fever. Some drugs used to treat bile duct cancer include 5-fluorouracil (5-fu), gemcitabine, cisplatin, capecitabine and oxaliplatin.
Market Analysis and Insights: Global Bile Duct Cancer Drugs Market
The global Bile Duct Cancer Drugs market size is projected to reach US$ million by 2026, from US$ million in 2020, at a CAGR of % during 2021-2026.
Global Bile Duct Cancer Drugs Scope and Segment
The global Bile Duct Cancer Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bile Duct Cancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
The major regions covered in the report are North America, Europe, China, Rest of Asia Pacific, Central & South America, Middle East & Africa, etc. It includes revenue analysis of each region for the year 2015 to 2026.
By the type, the market is primarily split into
5-Fluorouracil (5-FU)
Gemcitabine
Cisplatin
Capecitabine
Oxaliplatin
Others
By the application, this report covers the following segments
Hospitals & Clinic
Cancer Treatment Centers
Others
Competitive Landscape:
The Bile Duct Cancer Drugs key manufacturers in this market include:
Celgene
Mylan
Eli Lilly
Johnson & Johnson
Accord Healthcare
Roche
Teva
AbbVie
Bristol-Myers Squibb
Pfizer
Intercept Pharmaceuticals
Novartis
Sanofi
Kyowa Hakko Kirin
Delcath Systems
Fresenius Kabi
1 Market Overview of Bile Duct Cancer Drugs
1.1 Bile Duct Cancer Drugs Market Overview
1.1.1 Bile Duct Cancer Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global Bile Duct Cancer Drugs Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Bile Duct Cancer Drugs Market Size by Region (2015-2026)
1.4 Global Bile Duct Cancer Drugs Historic Market Size by Region (2015-2020)
1.5 Global Bile Duct Cancer Drugs Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Bile Duct Cancer Drugs Market Size YoY Growth (2015-2026)
1.6.1 North America Bile Duct Cancer Drugs Market Size YoY Growth (2015-2026)
1.6.2 Europe Bile Duct Cancer Drugs Market Size YoY Growth (2015-2026)
1.6.3 China Bile Duct Cancer Drugs Market Size YoY Growth (2015-2026)
1.6.4 Rest of Asia Pacific Bile Duct Cancer Drugs Market Size YoY Growth (2015-2026)
1.6.5 Latin America Bile Duct Cancer Drugs Market Size YoY Growth (2015-2026)
1.6.6 Middle East & Africa Bile Duct Cancer Drugs Market Size YoY Growth (2015-2026)
2 Bile Duct Cancer Drugs Market Overview by Type
2.1 Global Bile Duct Cancer Drugs Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Bile Duct Cancer Drugs Historic Market Size by Type (2015-2020)
2.3 Global Bile Duct Cancer Drugs Forecasted Market Size by Type (2021-2026)
2.4 5-Fluorouracil (5-FU)
2.5 Gemcitabine
2.6 Cisplatin
2.7 Capecitabine
2.8 Oxaliplatin
2.9 Others
3 Bile Duct Cancer Drugs Market Overview by Application
3.1 Global Bile Duct Cancer Drugs Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Bile Duct Cancer Drugs Historic Market Size by Application (2015-2020)
3.3 Global Bile Duct Cancer Drugs Forecasted Market Size by Application (2021-2026)
3.4 Hospitals & Clinic
3.5 Cancer Treatment Centers
3.6 Others
4 Global Bile Duct Cancer Drugs Competition Analysis by Players
4.1 Global Bile Duct Cancer Drugs Market Size (Million US$) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bile Duct Cancer Drugs as of 2019)
4.3 Date of Key Manufacturers Enter into Bile Duct Cancer Drugs Market
4.4 Global Top Players Bile Duct Cancer Drugs Headquarters and Area Served
4.5 Key Players Bile Duct Cancer Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Bile Duct Cancer Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Celgene
5.1.1 Celgene Profile
5.1.2 Celgene Main Business and Company’s Total Revenue
5.1.3 Celgene Products, Services and Solutions
5.1.4 Celgene Revenue (US$ Million) (2015-2020)
5.1.5 Celgene Recent Development and Reaction to Covid-19
5.2 Mylan
5.2.1 Mylan Profile
5.2.2 Mylan Main Business and Company’s Total Revenue
5.2.3 Mylan Products, Services and Solutions
5.2.4 Mylan Revenue (US$ Million) (2015-2020)
5.2.5 Mylan Recent Development and Reaction to Covid-19
5.3 Eli Lilly
5.5.1 Eli Lilly Profile
5.3.2 Eli Lilly Main Business and Company’s Total Revenue
5.3.3 Eli Lilly Products, Services and Solutions
5.3.4 Eli Lilly Revenue (US$ Million) (2015-2020)
5.3.5 Johnson & Johnson Recent Development and Reaction to Covid-19
5.4 Johnson & Johnson
5.4.1 Johnson & Johnson Profile
5.4.2 Johnson & Johnson Main Business and Company’s Total Revenue
5.4.3 Johnson & Johnson Products, Services and Solutions
5.4.4 Johnson & Johnson Revenue (US$ Million) (2015-2020)
5.4.5 Johnson & Johnson Recent Development and Reaction to Covid-19
5.5 Accord Healthcare
5.5.1 Accord Healthcare Profile
5.5.2 Accord Healthcare Main Business and Company’s Total Revenue
5.5.3 Accord Healthcare Products, Services and Solutions
5.5.4 Accord Healthcare Revenue (US$ Million) (2015-2020)
5.5.5 Accord Healthcare Recent Development and Reaction to Covid-19
5.6 Roche
5.6.1 Roche Profile
5.6.2 Roche Main Business and Company’s Total Revenue
5.6.3 Roche Products, Services and Solutions
5.6.4 Roche Revenue (US$ Million) (2015-2020)
5.6.5 Roche Recent Development and Reaction to Covid-19
5.7 Teva
5.7.1 Teva Profile
5.7.2 Teva Main Business and Company’s Total Revenue
5.7.3 Teva Products, Services and Solutions
5.7.4 Teva Revenue (US$ Million) (2015-2020)
5.7.5 Teva Recent Development and Reaction to Covid-19
5.8 AbbVie
5.8.1 AbbVie Profile
5.8.2 AbbVie Main Business and Company’s Total Revenue
5.8.3 AbbVie Products, Services and Solutions
5.8.4 AbbVie Revenue (US$ Million) (2015-2020)
5.8.5 AbbVie Recent Development and Reaction to Covid-19
5.9 Bristol-Myers Squibb
5.9.1 Bristol-Myers Squibb Profile
5.9.2 Bristol-Myers Squibb Main Business and Company’s Total Revenue
5.9.3 Bristol-Myers Squibb Products, Services and Solutions
5.9.4 Bristol-Myers Squibb Revenue (US$ Million) (2015-2020)
5.9.5 Bristol-Myers Squibb Recent Development and Reaction to Covid-19
5.10 Pfizer
5.10.1 Pfizer Profile
5.10.2 Pfizer Main Business and Company’s Total Revenue
5.10.3 Pfizer Products, Services and Solutions
5.10.4 Pfizer Revenue (US$ Million) (2015-2020)
5.10.5 Pfizer Recent Development and Reaction to Covid-19
5.11 Intercept Pharmaceuticals
5.11.1 Intercept Pharmaceuticals Profile
5.11.2 Intercept Pharmaceuticals Main Business and Company’s Total Revenue
5.11.3 Intercept Pharmaceuticals Products, Services and Solutions
5.11.4 Intercept Pharmaceuticals Revenue (US$ Million) (2015-2020)
5.11.5 Intercept Pharmaceuticals Recent Development and Reaction to Covid-19
5.12 Novartis
5.12.1 Novartis Profile
5.12.2 Novartis Main Business and Company’s Total Revenue
5.12.3 Novartis Products, Services and Solutions
5.12.4 Novartis Revenue (US$ Million) (2015-2020)
5.12.5 Novartis Recent Development and Reaction to Covid-19
5.13 Sanofi
5.13.1 Sanofi Profile
5.13.2 Sanofi Main Business and Company’s Total Revenue
5.13.3 Sanofi Products, Services and Solutions
5.13.4 Sanofi Revenue (US$ Million) (2015-2020)
5.13.5 Sanofi Recent Development and Reaction to Covid-19
5.14 Kyowa Hakko Kirin
5.14.1 Kyowa Hakko Kirin Profile
5.14.2 Kyowa Hakko Kirin Main Business and Company’s Total Revenue
5.14.3 Kyowa Hakko Kirin Products, Services and Solutions
5.14.4 Kyowa Hakko Kirin Revenue (US$ Million) (2015-2020)
5.14.5 Kyowa Hakko Kirin Recent Development and Reaction to Covid-19
5.15 Delcath Systems
5.15.1 Delcath Systems Profile
5.15.2 Delcath Systems Main Business and Company’s Total Revenue
5.15.3 Delcath Systems Products, Services and Solutions
5.15.4 Delcath Systems Revenue (US$ Million) (2015-2020)
5.15.5 Delcath Systems Recent Development and Reaction to Covid-19
5.16 Fresenius Kabi
5.16.1 Fresenius Kabi Profile
5.16.2 Fresenius Kabi Main Business and Company’s Total Revenue
5.16.3 Fresenius Kabi Products, Services and Solutions
5.16.4 Fresenius Kabi Revenue (US$ Million) (2015-2020)
5.16.5 Fresenius Kabi Recent Development and Reaction to Covid-19
6 North America Bile Duct Cancer Drugs by Players and by Application
6.1 North America Bile Duct Cancer Drugs Market Size and Market Share by Players (2015-2020)
6.2 North America Bile Duct Cancer Drugs Market Size by Application (2015-2020)
7 Europe Bile Duct Cancer Drugs by Players and by Application
7.1 Europe Bile Duct Cancer Drugs Market Size and Market Share by Players (2015-2020)
7.2 Europe Bile Duct Cancer Drugs Market Size by Application (2015-2020)
8 China Bile Duct Cancer Drugs by Players and by Application
8.1 China Bile Duct Cancer Drugs Market Size and Market Share by Players (2015-2020)
8.2 China Bile Duct Cancer Drugs Market Size by Application (2015-2020)
9 Rest of Asia Pacific Bile Duct Cancer Drugs by Players and by Application
9.1 Rest of Asia Pacific Bile Duct Cancer Drugs Market Size and Market Share by Players (2015-2020)
9.2 Rest of Asia Pacific Bile Duct Cancer Drugs Market Size by Application (2015-2020)
10 Latin America Bile Duct Cancer Drugs by Players and by Application
10.1 Latin America Bile Duct Cancer Drugs Market Size and Market Share by Players (2015-2020)
10.2 Latin America Bile Duct Cancer Drugs Market Size by Application (2015-2020)
11 Middle East & Africa Bile Duct Cancer Drugs by Players and by Application
11.1 Middle East & Africa Bile Duct Cancer Drugs Market Size and Market Share by Players (2015-2020)
11.2 Middle East & Africa Bile Duct Cancer Drugs Market Size by Application (2015-2020)
12 Bile Duct Cancer Drugs Market Dynamics
12.1 Covid-19 Impact: Industry Trends
12.2 Covid-19 Impact: Market Drivers
12.3 Covid-19 Impact: Market Challenges
12.4 Porter’s Five Forces Analysis
13 Research Finding /Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
